RSS-Feed abonnieren
DOI: 10.1055/s-0041-1728756
Selection Criteria for Lung Transplantation: Controversies and New Developments
Funding R.V. is supported by a research fellowship as senior clinical research fellow of Research Foundation—Flanders (FWO).![](https://www.thieme-connect.de/media/srccm/202103/lookinside/thumbnails/10-1055-s-0041-1728756_210302-1.jpg)
Abstract
Lung transplantation is an accepted therapeutic option for end-stage lung diseases. The imbalance between limited availability and vast need of donor organs necessitates careful selection of recipient candidates, ensuring the best possible utilization of the scarce resource of organs. Nonetheless, possible lung transplant candidates who could experience a meaningful improvement in survival and quality of life should not be excluded solely based on the complexity of their case. In this review, controversial issues or difficult limitations for lung transplantation, and new developments in recipient selection criteria, are discussed, which may help broaden recipient eligibility for lung transplantation without compromising long-term outcomes.
Keywords
lung transplantation - indication - contraindication - donor selection - recipient selection - selection criteriaAuthors' Contributions
H.B. performed research/study, collected data, wrote the manuscript, S.B. revised the data and manuscript critically, R.V. conceived and supervised the study and critically revised the data and the manuscript.
Publikationsverlauf
Artikel online veröffentlicht:
24. Mai 2021
© 2021. Thieme. All rights reserved.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 Ethics - General Considerations in Assessment for Transplant Candidacy - OPTN. [Cited January 14, 2021]. Accessed January 20, 2021 at: https://optn.transplant.hrsa.gov/resources/ethics/general-considerations-in-assessment-for-transplant-candidacy/
- 2 Orens JB, Estenne M, Arcasoy S. et al; Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2006; 25 (07) 745-755
- 3 Maurer JR, Frost AE, Estenne M, Higenbottam T, Glanville AR. International guidelines for the selection of lung transplant candidates. The International Society for Heart and Lung Transplantation, the American Thoracic Society, the American Society of Transplant Physicians, the European Respiratory Society. J Heart Lung Transplant 1998; 17 (07) 703-709
- 4 Weill D, Benden C, Corris PA. et al. A consensus document for the selection of lung transplant candidates: 2014--an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 2015; 34 (01) 1-15
- 5 Nathan SD. Lung transplantation: disease-specific considerations for referral. Chest 2005; 127 (03) 1006-1016
- 6 Fernandez R, Safaeinili N, Kurihara C. et al. Association of body mass index with lung transplantation survival in the United States following implementation of the lung allocation score. J Thorac Cardiovasc Surg 2018; 155 (04) 1871-1879.e3
- 7 Singer JP, Peterson ER, Snyder ME. et al. Body composition and mortality after adult lung transplantation in the United States. Am J Respir Crit Care Med 2014; 190 (09) 1012-1021
- 8 Lederer DJ, Wilt JS, D'Ovidio F. et al. Obesity and underweight are associated with an increased risk of death after lung transplantation. Am J Respir Crit Care Med 2009; 180 (09) 887-895
- 9 Halpern AL, Boshier PR, White AM. et al. A comparison of frailty measures at listing to predict outcomes after lung transplantation. Ann Thorac Surg 2020; 109 (01) 233-240
- 10 Hsu J, Krishnan A, Lin CT. et al. Sarcopenia of the psoas muscles is associated with poor outcomes following lung transplantation. Ann Thorac Surg 2019; 107 (04) 1082-1088
- 11 Chen X, Mao G, Leng SX. Frailty syndrome: an overview. Clin Interv Aging 2014; 9: 433-441
- 12 Singer JP, Diamond JM, Anderson MR. et al. Frailty phenotypes and mortality after lung transplantation: a prospective cohort study. Am J Transplant 2018; 18 (08) 1995-2004
- 13 Layton AM, Armstrong HF, Baldwin MR. et al. Frailty and maximal exercise capacity in adult lung transplant candidates. Respir Med 2017; 131: 70-76
- 14 Wilson ME, Vakil AP, Kandel P, Undavalli C, Dunlay SM, Kennedy CC. Pretransplant frailty is associated with decreased survival after lung transplantation. J Heart Lung Transplant 2016; 35 (02) 173-178
- 15 Stanjek-Cichoracka A, Woźniak-Grygiel E, Łaszewska A, Zembala M, Ochman M. Assessment of cytokines, biochemical markers of malnutrition and frailty syndrome patients considered for lung transplantation. Transplant Proc 2019; 51 (06) 2009-2013
- 16 Mitnitski AB, Mogilner AJ, MacKnight C, Rockwood K. The mortality rate as a function of accumulated deficits in a frailty index. Mech Ageing Dev 2002; 123 (11) 1457-1460
- 17 Kojima G, Iliffe S, Walters K. Frailty index as a predictor of mortality: a systematic review and meta-analysis. Age Ageing 2018; 47 (02) 193-200
- 18 Fried LP, Tangen CM, Walston J. et al; Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci 2001; 56 (03) M146-M156
- 19 Rockwood K, Song X, MacKnight C. et al. A global clinical measure of fitness and frailty in elderly people. CMAJ 2005; 173 (05) 489-495
- 20 Guralnik JM, Simonsick EM, Ferrucci L. et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994; 49 (02) M85-M94
- 21 Baldwin MR, Arcasoy SM, Shah A. et al. Hypoalbuminemia and early mortality after lung transplantation: a cohort study. Am J Transplant 2012; 12 (05) 1256-1267
- 22 Chamogeorgakis T, Mason DP, Murthy SC. et al. Impact of nutritional state on lung transplant outcomes. J Heart Lung Transplant 2013; 32 (07) 693-700
- 23 Bottiger BA, Nicoara A, Snyder LD. et al. Frailty in the end-stage lung disease or heart failure patient: implications for the perioperative transplant clinician. J Cardiothorac Vasc Anesth 2019; 33 (05) 1382-1392
- 24 Montgomery E, Macdonald PS, Newton PJ, Jha SR, Malouf M. Frailty in lung transplantation: a systematic review. Expert Rev Respir Med 2020; 14 (02) 219-227
- 25 Courtwright A, Cantu E. Lung transplantation in elderly patients. J Thorac Dis 2017; 9 (09) 3346-3351
- 26 Biswas Roy S, Alarcon D, Walia R, Chapple KM, Bremner RM, Smith MA. Is there an age limit to lung transplantation?. Ann Thorac Surg 2015; 100 (02) 443-451
- 27 Hayanga AJ, Aboagye JK, Hayanga HE. et al. Contemporary analysis of early outcomes after lung transplantation in the elderly using a national registry. J Heart Lung Transplant 2015; 34 (02) 182-188
- 28 Tang M, Mawji N, Chung S. et al. Factors affecting discharge destination following lung transplantation. Clin Transplant 2015; 29 (07) 581-587
- 29 Levy J, Kashem MA, Sunagawa G. et al. Analysis of UNOS database: survival outcome in elderly lung transplant recipients. J Heart Lung Transplant 2019; 38 (04) S412-S413
- 30 Ivulich S, Westall G, Dooley M, Snell G. The evolution of lung transplant immunosuppression. Drugs 2018; 78 (10) 965-982
- 31 Vadnerkar A, Toyoda Y, Crespo M. et al. Age-specific complications among lung transplant recipients 60 years and older. J Heart Lung Transplant 2011; 30 (03) 273-281
- 32 Conrad C, Cornfield DN. Pediatric lung transplantation: promise being realized. Curr Opin Pediatr 2014; 26 (03) 334-342
- 33 Sweet SC. Pediatric lung transplantation. Respir Care 2017; 62 (06) 776-798
- 34 Huddleston CB, Bloch JB, Sweet SC, de la Morena M, Patterson GA, Mendeloff EN. Lung transplantation in children. Ann Surg 2002; 236 (03) 270-276
- 35 Chambers DC, Yusen RD, Cherikh WS. et al; International Society for Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: Thirty-fourth Adult Lung and Heart-Lung Transplantation Report-2017; focus theme: allograft ischemic time. J Heart Lung Transplant 2017; 36 (10) 1047-1059
- 36 D'Ambrosio R, Aghemo A, Rossetti V, Carrinola R, Colombo M. Sofosbuvir-based regimens for the treatment of hepatitis C virus in patients who underwent lung transplant: case series and review of the literature. Liver Int 2016; 36 (11) 1585-1589
- 37 Woolley AE, Baden LR. Increasing access to thoracic organs from donors infected with hepatitis C: a previous challenge-now an opportunity. J Heart Lung Transplant 2018; 37 (05) 681-683
- 38 Manns M, Samuel D, Gane EJ. et al; SOLAR-2 Investigators. Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trial. Lancet Infect Dis 2016; 16 (06) 685-697
- 39 Colombo M, Aghemo A, Liu L. et al. GS13 - ledipasvir/sofosbuvir for 12 or 24 weeks is safe and effective in kidney transplant recipients with chronic genotype 1 or 4 Hcv infection. J Hepatol 2016; 64 (02) S183
- 40 Koenig A, Stepanova M, Saab S, Ahmed A, Wong R, Younossi ZM. Long-term outcomes of lung transplant recipients with hepatitis C infection: a retrospective study of the U.S. transplant registry. Aliment Pharmacol Ther 2016; 44 (03) 271-278
- 41 Doucette K, Sumner S, Weinkauf J. Treatment of hepatitis C in a lung transplant recipient with sofosbuvir and daclatasvir. J Heart Lung Transplant 2016; 35 (06) 840-841
- 42 Harano T, Haidar G, Schaheen L, Morrell MR, Pilewski JM, D'Cunha J. Successful lung transplantation from a hepatitis C RNA-positive donor to a hepatitis C treatment-experienced recipient with cystic fibrosis. J Thorac Cardiovasc Surg 2019; 158 (04) e155-e157
- 43 Khan B, Singer LG, Lilly LB. et al. Successful lung transplantation from hepatitis C positive donor to seronegative recipient. Am J Transplant 2017; 17 (04) 1129-1131
- 44 Abdelbasit A, Hirji A, Halloran K. et al. Lung transplantation from hepatitis C viremic donors to uninfected recipients. Am J Respir Crit Care Med 2018; 197 (11) 1492-1496
- 45 Transplanting Thoracic Organs from Hepatitis C Positive Donors to Hepatitis C Uninfected Recipients. clinicaltrials.gov. 2019 . [Cited May 18, 2020]. Accessed March 20, 2021 at: https://clinicaltrials.gov/ct2/show/NCT03086044
- 46 Samji H, Cescon A, Hogg RS. et al; North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada. PLoS One 2013; 8 (12) e81355
- 47 Bertani A, Grossi P, Vitulo P. et al. Successful lung transplantation in an HIV- and HBV-positive patient with cystic fibrosis. Am J Transplant 2009; 9 (09) 2190-2196
- 48 George MP. Time to reconsider transplant criteria for candidacy? Lung transplantation feasibility in HIV-infected patients. Ann Am Thorac Soc 2014; 11 (06) 962-963
- 49 Kern RM, Seethamraju H, Blanc PD. et al. The feasibility of lung transplantation in HIV-seropositive patients. Ann Am Thorac Soc 2014; 11 (06) 882-889
- 50 Van Pilsum Rasmussen SE, Bowring MG, Shaffer AA. et al. Knowledge, attitudes, and planned practice of HIV-positive to HIV-positive transplantation in US transplant centers. Clin Transplant 2018; 32 (10) e13365
- 51 Ambaraghassi G, Ferraro P, Poirier C, Rouleau D, Fortin C. Double lung transplantation in an HIV-positive patient with Mycobacterium kansasii infection. Transpl Infect Dis 2019; 21 (01) e12999
- 52 Ong S, Levy RD, Yee J. et al. Successful lung transplantation in an HIV seropositive patient with desquamative interstitial pneumonia: a case report. BMC Pulm Med 2018; 18 (01) 162
- 53 Calmy A, van Delden C, Giostra E. et al; Swiss HIV and Swiss Transplant Cohort Studies. HIV-positive-to-HIV-positive liver transplantation. Am J Transplant 2016; 16 (08) 2473-2478
- 54 Muller E, Barday Z, Kahn D. HIV-positive-to-HIV-positive kidney transplantation. N Engl J Med 2015; 372 (21) 2070-2071
- 55 Ingelfinger JR, Rubin EJ. The HIV-positive transplant donor--change born of necessity. N Engl J Med 2015; 372 (07) 663-665
- 56 Roland ME, Stock PG. Solid organ transplantation is a reality for patients with HIV infection. Curr HIV/AIDS Rep 2006; 3 (03) 132-138
- 57 Beeckmans H, Saez B, Van Herck A. et al. Lung transplantation and precision medicine. In: Gomez JL, Himes BE, Kaminski N. eds. Precision in Pulmonary, Critical Care, and Sleep Medicine: A Clinical and Research Guide. Cham: Springer International Publishing; 2020: 335-353
- 58 Koval C, Malinis M, Mueller N, Krisl J, Hannan M. Heart and lung transplantation outcomes in HIV-positive recipients. J Heart Lung Transplant 2019; 38 (12) 1296-1305
- 59 Katabathina VS, Menias CO, Tammisetti VS. et al. Malignancy after solid organ transplantation: comprehensive imaging review. Radiographics 2016; 36 (05) 1390-1407
- 60 Campistol JM, Cuervas-Mons V, Manito N. et al; ATOS Working Group. New concepts and best practices for management of pre- and post-transplantation cancer. Transplant Rev (Orlando) 2012; 26 (04) 261-279
- 61 Nair N, Gongora E, Mehra MR. Long-term immunosuppression and malignancy in thoracic transplantation: where is the balance?. J Heart Lung Transplant 2014; 33 (05) 461-467
- 62 Rudasill SE, Iyengar A, Sanaiha Y. et al. Pretransplant malignancy among lung transplant recipients in the modern era. Surgery 2019; 165 (06) 1228-1233
- 63 Al-Adra DP, Hammel L, Roberts J. et al. Pretransplant solid organ malignancy and organ transplant candidacy: a consensus expert opinion statement. Am J Transplant 2021; 21 (02) 460-474
- 64 Whitson BA, Shelstad RC, Hertz MI, Kelly RF, D'Cunha J, Shumway SJ. Lung transplantation after hematopoietic stem cell transplantation. Clin Transplant 2012; 26 (02) 254-258
- 65 Van Raemdonck D, Vos R, Yserbyt J, Decaluwe H, De Leyn P, Verleden GM. Lung cancer: a rare indication for, but frequent complication after lung transplantation. J Thorac Dis 2016; 8 (Suppl. 11) S915-S924
- 66 Copur MS, Wurdeman JM, Nelson D, Ramaekers R, Gauchan D, Crockett D. Normalization of elevated tumor marker CA27-29 after bilateral lung transplantation in a patient with breast cancer and idiopathic pulmonary fibrosis. Oncol Res 2018; 26 (03) 515-518
- 67 EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: Long-term management of the transplant recipient. IV.6.3. Cancer risk after renal transplantation. Solid organ cancers: prevention and treatment. Nephrol Dial Transplant 2002; 17 (Suppl. 04) 32-34–36
- 68 Cheng G-S, Edelman JD, Madtes DK, Martin PJ, Flowers MED. Outcomes of lung transplantation after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2014; 20 (08) 1169-1175
- 69 Soubani AO, Kingah P, Alshabani K, Muma G, Haq A. Lung transplantation following hematopoietic stem cell transplantation: report of two cases and systematic review of literature. Clin Transplant 2014; 28 (07) 776-782
- 70 Vogl UM, Nagayama K, Bojic M. et al. Lung transplantation for bronchiolitis obliterans after allogeneic hematopoietic stem cell transplantation: a single-center experience. Transplantation 2013; 95 (04) 623-628
- 71 Greer M, Riise GC, Hansson L. et al. Dichotomy in pulmonary graft-versus-host disease evident among allogeneic stem-cell transplant recipients undergoing lung transplantation. Eur Respir J 2016; 48 (06) 1807-1810
- 72 Jung HS, Lee JG, Yu WS, Lee CY, Haam SJ, Paik HC. Early outcomes of lung transplantation for bronchiolitis obliterans syndrome after allogeneic haematopoietic stem cell transplantation: a single-centre experience. Interact Cardiovasc Thorac Surg 2016; 23 (06) 914-918
- 73 Filipovich AH, Weisdorf D, Pavletic S. et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant 2005; 11 (12) 945-956
- 74 Sengsayadeth SM, Srivastava S, Jagasia M, Savani BN. Time to explore preventive and novel therapies for bronchiolitis obliterans syndrome after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 2012; 18 (10) 1479-1487
- 75 Jagasia MH, Greinix HT, Arora M. et al. National Institutes of Health Consensus Development Project on criteria for clinical trials in chronic graft-versus-host disease: I. The 2014 Diagnosis and Staging Working Group report. Biol Blood Marrow Transplant 2015; 21 (03) 389-401.e1
- 76 Mura M, Juvet S. Bronchiolitis obliterans syndrome as manifestation of lung GVHD: not the only one. Respirology 2019; 24 (07) 702
- 77 Holm AM, Riise GC, Hansson L. et al. Lung transplantation for bronchiolitis obliterans syndrome after allo-SCT. Bone Marrow Transplant 2013; 48 (05) 703-707
- 78 Sakaida E, Nakaseko C, Harima A. et al. Late-onset noninfectious pulmonary complications after allogeneic stem cell transplantation are significantly associated with chronic graft-versus-host disease and with the graft-versus-leukemia effect. Blood 2003; 102 (12) 4236-4242
- 79 Ren D, Kaleekal TS, Graviss EA. et al. Retransplantation outcomes at a large lung transplantation program. Transplant Direct 2018; 4 (11) e404
- 80 Kawut SM, Lederer DJ, Keshavjee S. et al. Outcomes after lung retransplantation in the modern era. Am J Respir Crit Care Med 2008; 177 (01) 114-120
- 81 Halloran K, Aversa M, Tinckam K. et al. Comprehensive outcomes after lung retransplantation: a single-center review. Clin Transplant 2018; 32 (06) e13281
- 82 Aigner C. Retransplantation. Curr Opin Organ Transplant 2015; 20 (05) 521-526
- 83 Novick RJ, Stitt LW, Al-Kattan K. et al. Pulmonary retransplantation: predictors of graft function and survival in 230 patients. Pulmonary Retransplant Registry. Ann Thorac Surg 1998; 65 (01) 227-234
- 84 Strueber M, Fischer S, Gottlieb J. et al. Long-term outcome after pulmonary retransplantation. J Thorac Cardiovasc Surg 2006; 132 (02) 407-412
- 85 Osho AA, Castleberry AW, Snyder LD. et al. Differential outcomes with early and late repeat transplantation in the era of the lung allocation score. Ann Thorac Surg 2014; 98 (06) 1914-1920 , discussion 1920–1921
- 86 Lindstedt S, Dellgren G, Iversen M. et al; Nordic Thoracic Transplantation Study Group (NTTSG). Pulmonary retransplantation in the Nordic countries. Ann Thorac Surg 2015; 99 (05) 1781-1787
- 87 Verleden SE, Todd JL, Sato M. et al. Impact of CLAD phenotype on survival after lung retransplantation: a multicenter study. Am J Transplant 2015; 15 (08) 2223-2230
- 88 Idrees JJ, Pettersson GB. State of the art of combined heart-lung transplantation for advanced cardiac and pulmonary dysfunction. Curr Cardiol Rep 2016; 18 (04) 36
- 89 Pinderski LJ, Kirklin JK, McGiffin D. et al. Multi-organ transplantation: is there a protective effect against acute and chronic rejection?. J Heart Lung Transplant 2005; 24 (11) 1828-1833
- 90 Rana A, Robles S, Russo MJ. et al. The combined organ effect: protection against rejection?. Ann Surg 2008; 248 (05) 871-879
- 91 Wolf JH, Sulewski ME, Cassuto JR. et al. Simultaneous thoracic and abdominal transplantation: can we justify two organs for one recipient?. Am J Transplant 2013; 13 (07) 1806-1816
- 92 Ceulemans LJ, Strypstein S, Neyrinck A. et al. Combined liver-thoracic transplantation: single-center experience with introduction of the ‘liver-first’ principle. Transpl Int 2016; 29 (06) 715-726
- 93 Yi SG, Burroughs SG, Loebe M. et al. Combined lung and liver transplantation: analysis of a single-center experience. Liver Transpl 2014; 20 (01) 46-53
- 94 Grannas G, Neipp M, Hoeper MM. et al. Indications for and outcomes after combined lung and liver transplantation: a single-center experience on 13 consecutive cases. Transplantation 2008; 85 (04) 524-531
- 95 Barshes NR, DiBardino DJ, McKenzie ED. et al. Combined lung and liver transplantation: the United States experience. Transplantation 2005; 80 (09) 1161-1167
- 96 Freischlag K, Schroder PM, Ezekian B. et al. Improved survival in simultaneous lung-liver recipients and candidates in the modern era of lung allocation. J Surg Res 2018; 231: 395-402
- 97 Freischlag K, Ezekian B, Schroder PM. et al. A propensity-matched survival analysis: do simultaneous liver-lung transplant recipients need a liver?. Transplantation 2019; 103 (08) 1675-1682
- 98 Reese PP, Veatch RM, Abt PL, Amaral S. Revisiting multi-organ transplantation in the setting of scarcity. Am J Transplant 2014; 14 (01) 21-26
- 99 Ruderman I, Sevastos J, Anthony C. et al. Outcomes of simultaneous heart-kidney and lung-kidney transplantations: the Australian and New Zealand experience. Intern Med J 2015; 45 (12) 1236-1241
- 100 Fridell JA, Wozniak TC, Powelson JA, Reynolds JM. Simultaneous bilateral lung and pancreas transplantation in recipient with cystic fibrosis. Transplant Proc 2008; 40 (02) 494-497
- 101 Mattar A, Chatterjee S, Loor G. Bridging to lung transplantation. Crit Care Clin 2019; 35 (01) 11-25
- 102 Halpern AL, Kohtz PD, Helmkamp L. et al. Improved mortality associated with the use of extracorporeal membrane oxygenation. Ann Thorac Surg 2019; 108 (02) 350-357
- 103 Tipograf Y, Salna M, Minko E. et al. Outcomes of extracorporeal membrane oxygenation as a bridge to lung transplantation. Ann Thorac Surg 2019; 107 (05) 1456-1463
- 104 Benazzo A, Schwarz S, Frommlet F. et al; Vienna ECLS Program. Twenty-year experience with extracorporeal life support as bridge to lung transplantation. J Thorac Cardiovasc Surg 2019; 157 (06) 2515-2525.e10
- 105 Hakim AH, Ahmad U, McCurry KR. et al. Contemporary outcomes of extracorporeal membrane oxygenation used as bridge to lung transplantation. Ann Thorac Surg 2018; 106 (01) 192-198
- 106 Kolaitis NA, Soong A, Shrestha P. et al. Improvement in patient-reported outcomes after lung transplantation is not impacted by the use of extracorporeal membrane oxygenation as a bridge to transplantation. J Thorac Cardiovasc Surg 2018; 156 (01) 440-448.e2
- 107 Yanagida R, Seethamraju H, Davenport DL, Tribble TA, Zwischenberger JB, Hoopes CW. Bridging to lung transplantation with double-lumen venovenous extracorporeal membrane oxygenation. Int J Artif Organs 2019; 42 (11) 621-627
- 108 Hayanga JWA, Lira A, Aboagye JK, Hayanga HK, D'Cunha J. Extracorporeal membrane oxygenation as a bridge to lung transplantation: what lessons might we learn from volume and expertise?. Interact Cardiovasc Thorac Surg 2016; 22 (04) 406-410
- 109 Lansink-Hartgring AO, van der Bij W, Verschuuren EA. et al. Extracorporeal life support as a bridge to lung transplantation: a single-center experience with an emphasis on health-related quality of life. Respir Care 2017; 62 (05) 588-594
- 110 Bernard GR, Artigas A, Brigham KL. et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994; 149 (3, Pt 1): 818-824
- 111 Matthay MA, Zemans RL, Zimmerman GA. et al. Acute respiratory distress syndrome. Nat Rev Dis Primers 2019; 5 (01) 18
- 112 Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 2000; 342 (18) 1334-1349
- 113 Combes A, Hajage D, Capellier G. et al; EOLIA Trial Group, REVA, and ECMONet. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome. N Engl J Med 2018; 378 (21) 1965-1975
- 114 Kielstein JT, Heiden AM, Beutel G. et al. Renal function and survival in 200 patients undergoing ECMO therapy. Nephrol Dial Transplant 2013; 28 (01) 86-90
- 115 Loor G, Simpson L, Parulekar A. Bridging to lung transplantation with extracorporeal circulatory support: when or when not?. J Thorac Dis 2017; 9 (09) 3352-3361
- 116 Iacono A, Groves S, Garcia J, Griffith B. Lung transplantation following 107 days of extracorporeal membrane oxygenation. Eur J Cardiothorac Surg 2010; 37 (04) 969-971
- 117 Salam S, Kotloff R, Garcha P. et al. Lung transplantation after 125 days on ECMO for severe refractory hypoxemia with no prior lung disease. ASAIO J 2017; 63 (05) e66-e68
- 118 Brichon PY, Barnoud D, Pison C, Perez I, Guignier M. Double lung transplantation for adult respiratory distress syndrome after recombinant interleukin 2. Chest 1993; 104 (02) 609-610
- 119 Jackson A, Cropper J, Pye R, Junius F, Malouf M, Glanville A. Use of extracorporeal membrane oxygenation as a bridge to primary lung transplant: 3 consecutive, successful cases and a review of the literature. J Heart Lung Transplant 2008; 27 (03) 348-352
- 120 Barrio J, Sánchez C, Vicente R. et al. Successful sequential double-lung transplantation for adult respiratory distress syndrome after long-term mechanical ventilation. Eur J Anaesthesiol 2004; 21 (04) 326-327
- 121 Jurmann MJ, Schaefers HJ, Demertzis S, Haverich A, Wahlers T, Borst HG. Emergency lung transplantation after extracorporeal membrane oxygenation. ASAIO J 1993; 39 (03) M448-M452
- 122 Guan W-J, Ni Z-Y, Hu Y. et al; China Medical Treatment Expert Group for COVID-19. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382 (18) 1708-1720
- 123 Han W, Zhu M, Chen J. et al. Lung transplantation for elderly patients with end-stage COVID-19 pneumonia. Ann Surg 2020; 272 (01) e33-e34
- 124 Lang C, Jaksch P, Hoda MA. et al. Lung transplantation for COVID-19-associated acute respiratory distress syndrome in a PCR-positive patient. Lancet Respir Med 2020; 8 (10) 1057-1060
- 125 Chen J-Y, Qiao K, Liu F. et al. Lung transplantation as therapeutic option in acute respiratory distress syndrome for coronavirus disease 2019-related pulmonary fibrosis. Chin Med J (Engl) 2020; 133 (12) 1390-1396
- 126 Hu C, Wang G, Zhou D. et al. The anesthetic management of the first lung transplant for a patient with COVID-19 respiratory failure. J Cardiothorac Vasc Anesth 2020
- 127 Bharat A, Querrey M, Markov NS. et al. Lung transplantation for patients with severe COVID-19. Sci Transl Med 2020; 12 (574) eabe4282
- 128 Chen X-J, Li K, Xu L. et al. Novel insight from the first lung transplant of a COVID-19 patient. Eur J Clin Invest 2021; 51 (01) e13443
- 129 Luo W-R, Yu H, Gou J-Z. et al. Histopathologic findings in the explant lungs of a patient with COVID-19 treated with bilateral orthotopic lung transplant. Transplantation 2020; 104 (11) e329-e331
- 130 Lyu H, Han W, Wang D, Liang T, Hu S. Perioperative mental evaluation and intervention for lung transplantation in elderly patients with COVID-19. Psychiatry Clin Neurosci 2020; 74 (10) 568-569
- 131 Ma Y, Meng H, Wang Y, Sun X, Chen Z. Perioperative infection prevention strategies for double-lung transplantation in elderly patients with COVID-19. [in Chinese]. Zhejiang Da Xue Xue Bao Yi Xue Ban 2020; 49 (05) 618-622
- 132 Yan Y, Jiang X, Fu J. et al. Immune responses and residual SARS-CoV-2 in two critically ill COVID-19 patients before and after lung transplantation. J Infect 2020; S0163-4453(20)30701-5
- 133 Wu B, Huang M, Jiao G, Hu C, Yang Y, Jingyu C. China Lung Transplantation Alliance, National Lung Transplantation Expert Group for COVID-19. Lung transplantation during the outbreak of Coronavirus Disease 2019 in China. J Thorac Cardiovasc Surg 2020; S0022-5223(20)33147-0
- 134 Helms J, Tacquard C, Severac F. et al; CRICS TRIGGERSEP Group (Clinical Research in Intensive Care and Sepsis Trial Group for Global Evaluation and Research in Sepsis). High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med 2020; 46 (06) 1089-1098
- 135 Ceulemans LJ, Van Slambrouck J, De Leyn P. et al. Successful double-lung transplantation from a donor previously infected with SARS-CoV-2. Lancet Respir Med 2020; S2213-2600(20)30524-5
- 136 Weinkauf J, Puttagunta L, Stewart K. et al. Lung transplantation for severe antineutrophilic cytoplasmic antibody-associated vasculitis. Transplant Proc 2010; 42 (07) 2707-2710
- 137 Sjöwall C, Mandl T, Skattum L, Olsson M, Mohammad AJ. Epidemiology of hypocomplementaemic urticarial vasculitis (anti-C1q vasculitis). Rheumatology (Oxford) 2018; 57 (08) 1400-1407
- 138 Yeatman M, McNeil K, Smith JA. et al. Lung transplantation in patients with systemic diseases: an eleven-year experience at Papworth Hospital. J Heart Lung Transplant 1996; 15 (02) 144-149
- 139 Silhan LL, Shah PD, Chambers DC. et al. Lung transplantation in telomerase mutation carriers with pulmonary fibrosis. Eur Respir J 2014; 44 (01) 178-187
- 140 Brestoff JR, Vessoni AT, Brenner KA. et al. Acute graft-versus-host disease following lung transplantation in a patient with a novel TERT mutation. Thorax 2018; 73 (05) 489-492
- 141 Borie R, Kannengiesser C, Hirschi S. et al; Groupe d'Etudes et de Recherche sur les Maladies “Orphelines” Pulmonaires (GERM“O”P). Severe hematologic complications after lung transplantation in patients with telomerase complex mutations. J Heart Lung Transplant 2015; 34 (04) 538-546
- 142 Tokman S, Singer JP, Devine MS. et al. Clinical outcomes of lung transplant recipients with telomerase mutations. J Heart Lung Transplant 2015; 34 (10) 1318-1324
- 143 Lebeer M, Wuyts WA, Cassiman D. et al. Multiple solid organ transplantation in telomeropathy: case series and literature review. Transplantation 2018; 102 (10) 1747-1755
- 144 Popescu I, Mannem H, Winters SA. et al. Impaired cytomegalovirus immunity in idiopathic pulmonary fibrosis lung transplant recipients with short telomeres. Am J Respir Crit Care Med 2019; 199 (03) 362-376
- 145 Courtwright AM, Fried S, Villalba JA. et al. Association of donor and recipient telomere length with clinical outcomes following lung transplantation. PLoS One 2016; 11 (09) e0162409
- 146 Faust HE, Golden JA, Rajalingam R. et al. Short lung transplant donor telomere length is associated with decreased CLAD-free survival. Thorax 2017; 72 (11) 1052-1054
- 147 Armando RG, Mengual Gomez DL, Maggio J, Sanmartin MC, Gomez DE. Telomeropathies: etiology, diagnosis, treatment and follow-up. Ethical and legal considerations. Clin Genet 2019; 96 (01) 3-16
- 148 Aubert G, Hills M, Lansdorp PM. Telomere length measurement-caveats and a critical assessment of the available technologies and tools. Mutat Res 2012; 730 (1-2): 59-67
- 149 Salvaterra E, Campo I. Pulmonary alveolar proteinosis: from classification to therapy. Breathe (Sheff) 2020; 16 (02) 200018
- 150 Trapnell BC, Nakata K, Bonella F. et al. Pulmonary alveolar proteinosis. Nat Rev Dis Primers 2019; 5 (01) 16
- 151 Suzuki T, Arumugam P, Sakagami T. et al. Pulmonary macrophage transplantation therapy. Nature 2014; 514 (7523): 450-454
- 152 Happle C, Lachmann N, Škuljec J. et al. Pulmonary transplantation of macrophage progenitors as effective and long-lasting therapy for hereditary pulmonary alveolar proteinosis. Sci Transl Med 2014; 6 (250) 250ra113
- 153 Takaki M, Tanaka T, Komohara Y. et al. Recurrence of pulmonary alveolar proteinosis after bilateral lung transplantation in a patient with a nonsense mutation in CSF2RB. Respir Med Case Rep 2016; 19: 89-93
- 154 Parker LA, Novotny DB. Recurrent alveolar proteinosis following double lung transplantation. Chest 1997; 111 (05) 1457-1458
- 155 Sim W, Kim SY, Han J. et al. Extracorporeal membrane oxygenation bridge to lung transplantation in a patient with Hermansky-Pudlak syndrome and progressive pulmonary fibrosis. Acute Crit Care 2019; 34 (01) 95-98
- 156 El-Chemaly S, O'Brien KJ, Nathan SD. et al. Clinical management and outcomes of patients with Hermansky-Pudlak syndrome pulmonary fibrosis evaluated for lung transplantation. PLoS One 2018; 13 (03) e0194193
- 157 Tager AM, Sharma A, Mark EJ. Case records of the Massachusetts General Hospital. Case 32-2009. A 27-year-old man with progressive dyspnea. N Engl J Med 2009; 361 (16) 1585-1593
- 158 Lederer DJ, Kawut SM, Sonett JR. et al. Successful bilateral lung transplantation for pulmonary fibrosis associated with the Hermansky-Pudlak syndrome. J Heart Lung Transplant 2005; 24 (10) 1697-1699
- 159 Colucci G, Stutz M, Rochat S. et al. The effect of desmopressin on platelet function: a selective enhancement of procoagulant COAT platelets in patients with primary platelet function defects. Blood 2014; 123 (12) 1905-1916
- 160 Cordova A, Barrios NJ, Ortiz I, Rivera E, Cadilla C, Santiago-Borrero PJ. Poor response to desmopressin acetate (DDAVP) in children with Hermansky-Pudlak syndrome. Pediatr Blood Cancer 2005; 44 (01) 51-54
- 161 Organ Procurement and Transplantation Network. Lung Kaplan-Meier patient survival rates for transplants performed: 2008–2015. [Cited October 19, 2020]. Accessed March 20, 2021 at: https://optn.transplant.hrsa.gov/data/view-data-reports/national-data/
- 162 Aigner C, Jaksch P, Taghavi S. et al. Pulmonary retransplantation: is it worth the effort? A long-term analysis of 46 cases. J Heart Lung Transplant 2008; 27 (01) 60-65
- 163 ISHLT. The International Society for Heart & Lung Transplantation. [Cited January 10, 2021]. Accessed March 20, 2021 at: https://ishltregistries.org/registries/slides.asp